Astellas Pharma Inc. specializes in the research, development, manufacturing and marketing of pharmaceutical products. Products are especially for immune diseases, infectious diseases, skin diseases, cancer and urologic disorders.
Number of employees : 15 883 people.
2019 2020 Delta JPY (in Million) % JPY (in Million) % Pharmaceutical 1,306,350 100% 1,300,840 100% -0.42%
2020 JPY (in Million) % United States 443,455 34.1% Japan 345,402 26.6% Established Markets 296,103 22.8% International 134,792 10.4% Greater China 60,367 4.6% Other 20,725 1.6%
Vote Quantity Free-Float Company-owned shares Total Float
Stock A
0.01
1,861,787,075
1,846,747,943
99.2% 4,313,167
0.2% 99.2%
Shareholders Astellas Pharma Inc. (JP3942400007) Astellas Pharma Inc. (US)
Name Equities % Nomura Asset Management Co., Ltd. 112,101,000
6.02% Nippon Life Insurance Co. 64,486,000
3.46% Sumitomo Mitsui Trust Asset Management Co., Ltd. 63,322,700
3.40% Nikko Asset Management Co., Ltd. 60,908,600
3.27% BlackRock Fund Advisors 60,791,229
3.27% The Vanguard Group, Inc. 52,267,073
2.81% Daiwa Asset Management Co. Ltd. 50,695,390
2.72% Wellington Management Co. LLP 37,508,177
2.01% Norges Bank Investment Management 36,123,710
1.94% BlackRock Japan Co., Ltd. 28,854,100
1.55%
Name Equities % Parametric Portfolio Associates LLC 2,446,946
0.13% Aperio Group LLC 759,899
0.041% The Renaissance Group LLC 591,985
0.032% Sector Gamma AS 476,941
0.026% Aristotle Capital Management LLC 442,510
0.024% Glenmede Investment Management LP 301,253
0.016% Todd Asset Management LLC 207,330
0.011% Teachers Retirement System of the State of Kentucky 207,330
0.011% Scout Investments, Inc. 184,816
0.0099% Nuveen Asset Management LLC 174,533
0.0094%
Name Equities % Valuation
FibroGen, Inc. (FGEN) 4,968,367 5.46% 184,276,732 USD Cytokinetics, Incorporated (CYTK) 2,040,816 2.88% 42,408,156 USD Astellas Pharma Inc. (4503) 1,196,800 0.064% 18,477,395 USD Oncolys BioPharma Inc. (4588) 727,200 4.97% 10,586,294 USD Hokuyaku Takeyama Holdings,Inc. (3055) 1,199,000 4.91% 8,733,096 USD Brickell Biotech, Inc. (BBI) 12,303 0.023% 9,596 USD Plus Therapeutics, Inc. (PSTV) 191 0.0040% 386 USD
-
- First Section
- Nikkei 225 / Stoxx Asia Pacific 50
- Bloomberg Code :
4503:JP
- Reuters Code :
4503.T
- Datastream Code :
Company contact information
Astellas Pharma Inc.
2-5-1 Nihonbashi-Honcho
JP-103-8411 Chuo-ku, Tokyo
Phone : +81 3 3244 3000
Fax :
web site :
http://www.astellas.com
Sector Pharmaceuticals - NEC
Connections : Astellas Pharma Inc.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
